Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...

The pharmaceutical industry, grappling with new government limits on drug prices, is focusing its requests for ...

Midan included 10 trends with implications for the meat industry while identifying two macro-factors that are expected to ...

Novo Nordisk's shares plummeted due to disappointing trial results for CagriSema, with patients achieving only 22.7% weight ...

The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

While weight loss is a common new year's resolution for workers in the U.S., 2025 may mark the year that building weight loss ...

During a roughly five-year span, CVS Health, Cigna, and UnitedHealth benefited the most from increasing prices for generic drugs that treated illnesses such as HIV and cancer. Some of the price hikes ...

A new generation of weight loss drugs has helped some people lose significant amounts of weight and improve their health.

January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...

For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that from 2021 to 2023, those rates dropped from 41.9% to 40.3%.

Drugs like Ozempic and Wegovy are now costing Connecticut taxpayers about $60 million this year and that figure could rise ...